Bio-Medical Applications of Lewiston, Inc. v. United States

17 Cl. Ct. 84, 1989 U.S. Claims LEXIS 88, 1989 WL 53873
CourtUnited States Court of Claims
DecidedMay 23, 1989
DocketNo. 32-88C
StatusPublished
Cited by1 cases

This text of 17 Cl. Ct. 84 (Bio-Medical Applications of Lewiston, Inc. v. United States) is published on Counsel Stack Legal Research, covering United States Court of Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bio-Medical Applications of Lewiston, Inc. v. United States, 17 Cl. Ct. 84, 1989 U.S. Claims LEXIS 88, 1989 WL 53873 (cc 1989).

Opinion

OPINION

BRUGGINK, Judge.

This is an action for reimbursement for the supply of Medicare services. Plaintiffs are Bio-Medical Applications of Lewiston, Inc. (“BMA”), and its parent company, Bio1Medical Applications Management Co., Inc.

Plaintiffs seek $24,886.14 plus interest for dialysis treatments rendered to Medicare patients at BMA’s facility between October 2, 1984 and November 1, 1984.1 Pursuant to RUSCC 56(b), defendant has moved for summary judgment. Plaintiffs have replied that a disputed issue of mate[86]*86rial fact exists, but in the alternative, seek summary judgment by cross-motion. In aid of its motion for summary judgment, defendant also moves to strike two affidavits plaintiffs submitted in opposition to summary judgment. For the reasons which follow, both defendant’s motion to strike the affidavit of Susan Robers, and its motion for summary judgment are due to be granted.

BACKGROUND

Pursuant to the Social Security Act, Medicare coverage is provided to patients with end-stage renal disease (“ESRD”). 42 U.S.C. § 1395rr(b)(l). The Secretary of Health and Human Services has delegated responsibility for administration of the Medicare program to the Health Care Financing Administration (“HCFA”). Hospitals, clinics, and certain other health care facilities providing dialysis treatment to ESRD patients are reimbursed by Medicare, provided that the facilities meet conditions of coverage and other requirements as set forth in the Medicare regulations promulgated by HHS pursuant to the act. See 42 C.F.R. § 405.2100, et seq. Each condition of coverage in turn is divided into two or more health and safety standards.

BMA, which operates a renal dialysis facility in Lewiston, Maine, sought approval for reimbursement by HCFA for dialysis services to Medicare patients. As a service to HHS, the Division of Licensing and Certification of the Maine Department of Human Services (“Maine survey agency”) conducted an on-site inspection of the facility to determine whether BMA satisfied the applicable requirements for certification. The inspection was completed on October 3, 1984, and the Maine survey agency concluded that BMA was in compliance with the conditions of coverage applicable to ESRD facilities, but BMA was found to be in noncompliance with one standard of coverage within each of two conditions.

On October 25, 1984, the Maine survey agency notified BMA in writing of the deficiencies identified during the survey, and BMA submitted a plan for correcting these deficiencies on November 1, 1984. By letter of May 7, 1985, HCFÁ approved BMA’s plan of corrections and notified BMA that it was eligible for participation in the Medicare program as of November 12,1984, the date certain corrections were to have been made by BMA. BMA thereafter sought a certification determination retroactive to the October 2 survey date; HCFA denied the request, but agreed to roll back certification to November 1, the date that BMA submitted its plan of correction.

Between October 2, 1984 and November 1, 1984, BMA provided Medicare patients with 229 dialysis treatments and related services. Based upon reimbursement rates approved by HCFA, plaintiffs claim that these services would have resulted in a $24,886.14 payment to BMA.

By letter of June 28, 1985, BMA requested that HCFA reconsider its effective date of certification for the Lewiston facility. HCFA reaffirmed its decision by letter of July 18, 1985. The regulations promulgated by HCFA to implement its responsibilities under the Act do not explicitly address the date upon which a health care supplier’s certification becomes effective. Instead, HCFA based its decision on a reading of 42 C.F.R. § 489.13, which provides in relevant part, with respect to providers:

Section 489.13 Effective Date of Agreement
(b) All Federal requirements are not met on the date of the survey. If the provider fails to meet any of the requirements ... [health and safety standards and other HCFA requirements] the agreement will be effective on the earlier of the following dates:
(1) the date on which the provider meets all requirements.
(2) the date on which the provider submits a correction plan acceptable to HCFA....

Section 405.1901(a) sets out the distinction between a provider and a supplier of services:

Provider of services or provider means a hospital, skilled nursing facility, home health agency, hospice, comprehensive outpatient rehabilitation facility or pro[87]*87vider of outpatient physical therapy or speech pathology services.
Supplier means any of the following: independent laboratory; portable X-ray services; physical therapist in independent practice; ESRD facility; rural health clinic; or chiropractor.

It is thus clear that plaintiffs, as the owner and operator of an ESRD facility, are suppliers of services.

BMA appealed HCFA’s decision to an Administrative Law Judge (“AU”), and on April 9, 1986, the AU affirmed the agency’s decision. The AU’s rationale was identical to that of the HCFA. In both instances, 42 C.F.R. § 489.13 was applied to plaintiffs’ ESRD facility, with the result that the effective date of agreement between BMA and HCFA was found to be the date that BMA submitted an acceptable plan of correction — November 1, 1984. The AU stated that although BMA was “technically correct” in its assertion that § 489.13 was a provider regulation and therefore inapplicable to a supplier, the regulation should be extended to cover suppliers since there was no meaningful distinction between suppliers and providers.

BMA sought final agency review in the Appeals Council of the Department of Health and Human Services. By decision dated February 26,1987, the Appeals Council affirmed the AU’s determination that the certification became effective on the date when the facility submitted its plan of correction. It specifically rejected the applicability of § 489.13, however, on the theory that it applied only to providers and not to suppliers. Instead the Appeals Council relied on 42 C.F.R. § 405.1907(a). That section provides in relevant part:

If a provider or supplier is found to be deficient with respect to one or more of the standards in the conditions of participation or conditions for coverage, it may participate in or be covered under the Health Insurance for the Aged and Disabled Program only if the facility has submitted an acceptable plan of correction for achieving compliance within a reasonable period of time acceptable to the Secretary.

BMA filed suit in United States District Court for the District of Massachusetts on April 27, 1987. That action was transferred to this court by Judge Keeton’s order dated December 30, 1987, 677 F.Supp. 51 (1987).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Moyer v. United States
41 Fed. Cl. 324 (Federal Claims, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
17 Cl. Ct. 84, 1989 U.S. Claims LEXIS 88, 1989 WL 53873, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bio-medical-applications-of-lewiston-inc-v-united-states-cc-1989.